Dana Vanderwall on Cheminformatics at Drexel
Dana Vanderwall, Associate Director of Cheminformatics at Bristol-Myers Squibb, presented for my last Chemical Information Retrieval class on December 2, 2010.
The first part covered "Cheminformatics & The evolving relationship between data in the public domain & pharma" and included a general discussion of modern drug discovery and the details of a malaria dataset recently released from the pharmaceutical industry to the public.
The second part described a project based on "Molecular Clinical Safety Intelligence", where tracking side effects from approved drugs can help in the design of new drugs.
It was a very nice way to close out the course, showing very practical applications of the concepts we covered over the term. The recording is available below.
Labels: BMS, Drug discovery, malaria, open data
posted by Jean-Claude Bradley @ Sunday, December 05, 2010
2 comments
2 Comments:
Slide 7 of the first part caught my eye... "chemical structures are the IP". In fact, it's the properties chemicals have where the knowledge is. As such, a shortlist of chemicals is indeed a treasure map. And cheminformatics is like the Google cars that drive around the world to make a mao.
Egon - I agree and that is why I was impressed that they still tried to find a way to share this without disclosing their libraries
Post a Comment
<< Home